Clonidine in Korsakoff disease: pathophysiologic and therapeutic implications.
D000425:Alcohol Amnestic Disorder / Q000188:drug therapy* / Q000473:pathology; D000818:Animals; D001921:Brain / Q000473:pathology; D003000:Clonidine / Q000627:therapeutic use*; D003913:Dextroamphetamine / Q000627:therapeutic use; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D011939:Mental Recall / Q000187:drug effects; D008734:Methoxyhydroxyphenylglycol / Q000134:cerebrospinal fluid; D008784:Methysergide / Q000627:therapeutic use; D011941:Receptors, Adrenergic / Q000187:drug effects
D011941:Receptors, Adrenergic; D008734:Methoxyhydroxyphenylglycol; D006897:Hydroxyindoleacetic Acid; D003000:Clonidine; D003913:Dextroamphetamine; D008784:Methysergide